Xiao-Nan Huang

Xiao-Nan Huang

Auto-generated profile, based on publicly available information

Xiao-Nan Huang

Key Laboratory of Biopharmaceutical Preparation and Delivery, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, 100190, PR China; University of Chinese Academy of Sciences, Beijing, 100049, PR China

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Research
Verified
Journal Article
Open access
XHXiaonan Huang
Xiaonan Huang
YMYishan Ma
Yishan Ma
Guanghui MaGuanghui Ma
Guanghui Ma
YXYufei Xia
Yufei Xia
Messenger RNA (mRNA) has emerged as an innovative therapeutic modality, offering promising avenues for the prevention and treatment of a variety of diseases. The tremendous success of mRNA vaccines in effectively combatting coronavirus disease 2019 (COVID-19) evidences the unlimited medical and therapeutic potential of mRNA technology. Overcoming challenges related to mRNA stability, immunogenicity, and precision targeting has been made possible by recent advancements in lipid nanoparticles (LNPs). This review summarizes state-of-the-art LNP-mRNA-based therapeutics, including their structure, material compositions, design guidelines, and screening principles. Additionally, we highlight current preclinical and clinical trends in LNP-mRNA therapeutics in a broad range of treatments in ophthalmological conditions, cancer immunotherapy, gene editing, and rare-disease medicine. Particular attention is given to the translation and evolution of LNP-mRNA vaccines into a broader spectrum of therapeutics. We explore concerns in the aspects of inadequate extrahepatic targeting efficacy, elevated doses, safety concerns, and challenges of large-scale production procedures. This discussion may offer insights and perspectives on near- and long-term clinical development prospects for LNP-mRNA therapeutics.

1 October 2015 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
ZGZhi-Qiang Ge
Zhi-Qiang Ge
XDXin-Ying Du
Xin-Ying Du
XHXiao-Nan Huang
Xiao-Nan Huang
BQBin Qiao
Bin Qiao

1 September 2016 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
XHXiao-Nan Huang
Xiao-Nan Huang
XDXin-Ying Du
Xin-Ying Du
JXJin-Feng Xing
Jin-Feng Xing
ZGZhi-Qiang Ge
Zhi-Qiang Ge

6 September 2025 in Biomaterials
Verified
Journal Article
Closed access
YSYu Sun
Yu Sun
HNHideki Nakanishi
Hideki Nakanishi
XHXiaonan Huang
Xiaonan Huang
GMGuanghui Ma
Guanghui Ma
XGXiao-Dong Gao
Xiao-Dong Gao
YXYufei Xia
Yufei Xia